CLINICAL_TRIALS
trial_result
· 2013-11-01
Clinical Trial Update: Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer [Phase 2]
Summary
Phase 2 neoadjuvant study of weekly ixabepilone in high-risk, localized prostate cancer completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brown University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-11-01